{"id":"W2083791045","doi":"10.2165/00019053-200624080-00007","title":"Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Merck Canada Inc. (Canada)","funders":"","keywords":"Ezetimibe; Atorvastatin; Quality of Life Research; Health economics; Medicine; Public health; Ldl cholesterol; Pharmacotherapy; Cholesterol; Cost effectiveness; Intensive care medicine; Internal medicine; Risk analysis (engineering)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000300303,0.0001489942,0.0004532267,0.00009624192,0.0000196212,0.000004566583,0.00005317255,0.00002755349,0.00003271838],"category_scores_gemma":[0.000004923239,0.0001404353,0.0000783615,0.00008495602,0.000009417297,0.00004193293,0.00002281389,0.00007286546,0.000006492751],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004231009,"about_ca_system_score_gemma":0.0004886613,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7440121,"about_ca_topic_score_gemma":0.4930065,"domain_scores_codex":[0.9989182,0.0001081085,0.0003513254,0.0002421182,0.0001200312,0.0002602338],"domain_scores_gemma":[0.9995363,0.000065607,0.00007212131,0.0001849504,0.00002844363,0.0001125817],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001644336,0.0002894054,0.9231113,0.00009533914,0.00007253715,0.00001421416,0.000111025,0.004497523,0.001971076,0.00000476459,0.0000776362,0.06811083],"study_design_scores_gemma":[0.01310254,0.0002376895,0.9136555,0.00006616818,0.00001556792,0.000001978702,0.00001734574,0.0002650176,0.06980085,0.000001291485,0.002719668,0.0001164319],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977213,0.00007761513,0.000007598323,0.00007562025,0.0001553379,0.00168311,0.00009566193,0.000005390199,0.0001783911],"genre_scores_gemma":[0.999007,0.00009467942,0.00006873551,0.0004796613,0.00006199424,0.0001872768,0.00006174472,0.00002401148,0.00001488819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2510056,"threshold_uncertainty_score":0.9995916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02107101357976402,"score_gpt":0.2939922897417853,"score_spread":0.2729212761620212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}